Restore Medical
Revolution in heart failure — the first transcatheter Pulmonary Artery Banding system
- Headquarters
- Or-Yehuda
- Employees
- 1–10
- Business Model
- B2B
- Website
- restoremedical.co
- Last Round
- Series BDec 2024
- Rounds
- 1
About
Restore Medical is a privately held Israeli clinical-stage medical device company dedicated to transforming the treatment of congestive heart failure (CHF). The company has developed ContraBand™, the first and only transcatheter Pulmonary Artery Banding (PAB) system for treating HFrEF (Heart Failure with reduced Ejection Fraction) patients. ContraBand is a reversible, catheter-delivered implant that leverages the right ventricle to support the left ventricle, improving LV ejection fraction and restoring optimal ventricular geometry. The device received FDA Breakthrough Device Designation in July 2024. Restore Medical secured $23M in funding in 2025 and previously received €2.5M in EU funding plus a €10M EIC equity commitment.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Dec 2024
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
operates in the healthcare industry focusing on biotechnology business
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...